| Title : Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial - Falchook_2012_Lancet_379_1893 |
| Author(s) : Falchook GS , Long GV , Kurzrock R , Kim KB , Arkenau TH , Brown MP , Hamid O , Infante JR , Millward M , Pavlick AC , O'Day SJ , Blackman SC , Curtis CM , Lebowitz P , Ma B , Ouellet D , Kefford RF |
| Ref : Lancet , 379 :1893 , 2012 |
| Abstract : Falchook_2012_Lancet_379_1893 |
| ESTHER : Falchook_2012_Lancet_379_1893 |
| PubMedSearch : Falchook_2012_Lancet_379_1893 |
| PubMedID: 22608338 |
Falchook GS, Long GV, Kurzrock R, Kim KB, Arkenau TH, Brown MP, Hamid O, Infante JR, Millward M, Pavlick AC, O'Day SJ, Blackman SC, Curtis CM, Lebowitz P, Ma B, Ouellet D, Kefford RF (2012)
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
Lancet
379 :1893
Falchook GS, Long GV, Kurzrock R, Kim KB, Arkenau TH, Brown MP, Hamid O, Infante JR, Millward M, Pavlick AC, O'Day SJ, Blackman SC, Curtis CM, Lebowitz P, Ma B, Ouellet D, Kefford RF (2012)
Lancet
379 :1893